Long intergenic non-protein coding RNA 2628 (LINC02628)

Long intergenic non-protein coding RNA 2628 (LINC02628) is a human gene that codes for a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) autonomously transcribed as RNA molecules longer than 200 nucleotides which do not overlap with protein-coding genes[1]. lincRNAs overall serve various gene regulatory functions, including modulation of chromatin architecture, scaffolding of protein complexes, regulation of neighboring gene transcription, RNA stabilization, and enhancer activities[1]. Although the broader functional significance of lincRNAs in gene regulation and disease states is well established, very few lincRNAs, including LINC02628, have been individually characterized[1]. There are currently no published data reporting specific biological functions, disease roles, or pharmacological targeting for LINC02628 as of the latest research. Interpretation and limitations: LINC02628 is recognized as a lincRNA and not as a conventional therapeutic target such as a receptor, enzyme, or transporter. No alternative names or disease links have been described in the literature for LINC02628. Drug interactions, mechanisms of drug action, and biomarker use for patient selection/monitoring have not been reported specifically for this lincRNA. This entry is not misspelled, but information about this specific lincRNA is extremely limited or absent in scientific databases as of the current date. Summary: LINC02628 is a long intergenic non-protein coding RNA whose functions and disease relevance have not yet been specifically established, although it belongs to the class of lincRNAs involved in general gene regulatory activities[1].